Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “HEPAREGENIX GMBH”

4 pharma patents match "HEPAREGENIX GMBH" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "HEPAREGENIX GMBH" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “HEPAREGENIX GMBH” · 30,257 patents in full index Clear search

  1. US 12264158

    Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

    HEPAREGENIX GMBH · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  2. US 11858927

    Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

    HEPAREGENIX GMBH · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  3. US 11731968

    Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

    HEPAREGENIX GMBH · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  4. US 11040027

    Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

    HEPAREGENIX GMBH · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted